	US 11,905,334 B2
	Anti-human VSIG4 antibodies and uses thereof
Byoung S. Kwon, Seoul (KR); Hye Jeong Kim, Seoul (KR); Sunhee Hwang, Seoul (KR); Joongwon Lee, Seoul (KR); Seung Hyun Lee, Seoul (KR); Sun Woo Im, Seoul (KR); Jin Kyung Choi, Seoul (KR); Hyun Tae Son, Seoul (KR); and Hyeok-Jun Park, Seoul (KR)
Filed by Eutilex Co., Ltd., Seoul (KR)
Filed on Feb. 5, 2021, as Appl. No. 17/169,095.
Application 17/169,095 is a continuation of application No. 16/838,887, filed on Apr. 2, 2020, granted, now 10,927,183.
Application 16/838,887 is a continuation of application No. PCT/US2019/053824, filed on Sep. 30, 2019.
Claims priority of provisional application 62/776,523, filed on Dec. 7, 2018.
Claims priority of provisional application 62/738,255, filed on Sep. 28, 2018.
Prior Publication US 2021/0261681 A1, Aug. 26, 2021
This patent is subject to a terminal disclaimer.
Int. Cl. C07K 16/28 (2006.01); C12N 15/85 (2006.01); A61P 35/00 (2006.01); C07K 16/30 (2006.01); A61K 45/06 (2006.01); A61K 39/00 (2006.01)

CPC C07K 16/30 (2013.01) [A61P 35/00 (2018.01); C07K 16/2803 (2013.01); C12N 15/85 (2013.01); A61K 45/06 (2013.01); A61K 2039/505 (2013.01); C07K 2317/24 (2013.01); C07K 2317/51 (2013.01); C07K 2317/515 (2013.01); C07K 2317/56 (2013.01); C07K 2317/92 (2013.01)]

15 Claims

1. A recombinant vector comprising a nucleic acid molecule encoding an anti-V-Set and Immunoglobulin Domain Containing 4 (VSIG4) antibody or antigen-binding fragment comprising a heavy chain variable domain comprising the amino acid sequence of SEQ ID NO: 6.